Hologic, Inc. HOLX | NASDAQ

$71.65 $0.89 | 1.26%

After Hours
$72.2 $0.55 | 0.77%

Next Earnings: Jan 30, 2025

Company Overview:

Market Cap: $16.26B
PE Ratio: 21.58
52-Week Range: $70.36 - $84.67
Dividend Yield (FWD): 0.00% ($0.00)

10 Year Performance Metrics:

Total Return (with DRIP): 164.88% (10.23% / yr)
Total Return (no DRIP): 164.88% (10.23% / yr)
Share Price: 164.88%
Dividend Increase: nan%
HOLX 10-yr Total Return ($10,000 investment)
1Y 2Y 5Y 10Y All

HOLX Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
HOLX Dividend CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Share Price
HOLX Price CAGR:1Y: 1.89%2Y: -1.67%5Y: 6.61%10Y: 10.28%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

HOLX Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend payout ration is Dividend/EPS, and indicates if company can afford to pay dividends from net income that it earned in the quarter.

Since EPS can be played with using different "accounting gymnastics", a better measure of dividends safety is Dividend to Free Cash Flow (FCF) ratio.

FCF is how much cash the company has earned each quarter, after paying all expenses not related to earnings.

Lower Ratio indicates SAFER Dividend! Ratios consistently close to, or over 100% are usually unsustainable and often indicate a dividend cut might be coming soon.

Dividend Payout Ratio - HOLX
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - HOLX
14-Day FREE Trial Get Full Access Now!

HOLX Earnings, Revenue, Cash & Debt, Shares Outstaning:

HOLX - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
HOLX - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
HOLX - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
HOLX - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
HOLX - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
HOLX - Cash & Debt
14-Day FREE Trial Get Full Access Now!
HOLX - Revenue
14-Day FREE Trial Get Full Access Now!
HOLX Revenue CAGR:1Y: 4.51%2Y: 1.80%5Y: 2.67%10Y: 4.11%
HOLX - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
HOLX EPS CAGR:1Y: 105.41%2Y: 27.16%5Y: 38.34%10Y: 22.48%
HOLX - Net Income
14-Day FREE Trial Get Full Access Now!
HOLX Net Income CAGR:1Y: 97.13%2Y: 22.66%5Y: 34.95%10Y: 20.31%
HOLX - EBITDA
14-Day FREE Trial Get Full Access Now!
HOLX EBITDA CAGR:1Y: 7.40%2Y: 25.38%5Y: 27.00%10Y: 8.88%
HOLX - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
HOLX Free Cash Flow CAGR:1Y: 63.29%2Y: 56.77%5Y: 9.25%10Y: 11.91%
HOLX - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
HOLX Free Cash Flow / Share CAGR:1Y: 71.22%2Y: 62.21%5Y: 12.36%10Y: 13.86%
HOLX - Gross Profit
14-Day FREE Trial Get Full Access Now!
HOLX Gross Profit CAGR:1Y: 11.45%2Y: 4.08%5Y: 7.59%10Y: 4.92%
HOLX - Expenses
14-Day FREE Trial Get Full Access Now!
HOLX Expenses CAGR:1Y: -42.29%2Y: -2.08%5Y: -0.71%10Y: 3.07%
HOLX - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
HOLX Shares Outstanding CAGR:1Y: -4.52%2Y: -3.34%5Y: -2.73%10Y: -1.77%
HOLX - Share Buybacks
14-Day FREE Trial Get Full Access Now!
HOLX Share Buybacks CAGR:1Y: -72.40%2Y: -42.30%5Y: 170.85%10Y: 58.03%
HOLX - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
HOLX Stock-Based Comp CAGR:1Y: -100.00%2Y: -100.00%5Y: -100.00%10Y: -100.00%
HOLX - Dividends
14-Day FREE Trial Get Full Access Now!
HOLX Dividend CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
HOLX - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
HOLX Revenue CAGR:1Y: 4.51%2Y: 1.80%5Y: 2.67%10Y: 4.11%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

HOLX - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
HOLX Actual Revenue CAGR:1Y: 4.51%2Y: 1.80%5Y: 2.67%10Y: 4.11%
HOLX - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
HOLX Actual EPS CAGR:1Y: 105.41%2Y: 27.16%5Y: 38.34%10Y: 22.48%
HOLX - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
HOLX Actual Net Income CAGR:1Y: 97.13%2Y: 22.66%5Y: 34.95%10Y: 20.31%
HOLX - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
HOLX Actual EBITDA CAGR:1Y: 7.40%2Y: 25.38%5Y: 27.00%10Y: 8.88%

Ratios, Profit Margins & Return on Capital:

HOLX - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
HOLX Net Profit Margin CAGR:1Y: 88.73%2Y: 20.51%5Y: 31.43%10Y: 15.58%
HOLX - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
HOLX Gross Profit Margin CAGR:1Y: 6.63%2Y: 2.23%5Y: 4.79%10Y: 0.78%
HOLX - Price to Earnings
14-Day FREE Trial Get Full Access Now!
HOLX - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
HOLX - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
HOLX - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

HOLX Dividends Info:

Annual Dividend: $
Forward Yield: 0%
Ex-Dividend Date:
Lifetime Dividens / Share: $0.00

HOLX Dividend History: Dates, Payments & Yield list

Below is a schedule of all HOLX dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Projected Future Returns & Dividends for HOLX

Based on past 10-year performance, here are HOLX growth metrics:

Share price CAGR of +10.23%
Dividend CAGR of +0%
Using HOLX CAGR metrics, we can estimate, that your initial $10000 investment, over next 10 years ago, should grow with dividends being reinvested (DRIP) as follows:

HOLX
Current Price$71.65
Start Shares139.57
Start Value$10,000
 
After 10 years:
Final Share Count139.57
Dividends Payment$0.00
Annual Dividends$0
Yield on cost0.00%
Share Price$172.17
Total Dividends$0
Final Value$24,029

Estimated Future Value + Dividends - HOLX

NOTE: Above numbers are our estimate based on HOLX's Dividend and Price CAGR over past 10 years. These numebrs should only be considered as "potential future returns"! These numbers assume DRIP (reinvesting dividends).

We cannot guarantee that your actual returns will meet these estimates.

Company Info

Hologic, Inc. (HOLX) had its IPO on 1990-03-01, and is trader on NASDAQ stock exchange.

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

HOLX website: https://www.hologic.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial